Foods Alive — Moringa Leaf Powder
Potential to be contaminated with Salmonella
Read FDA’s announcement (opens in a new tab)Data last updated: September 6, 2026 at 10:21 PM UTC
16,585 recalls foundPotential to be contaminated with Salmonella
Read FDA’s announcement (opens in a new tab)Products contain undeclared yohimbine
Read FDA’s announcement (opens in a new tab)Possible E. Coli Contamination
Read FDA’s announcement (opens in a new tab)Presence of particulate matter identified as iron oxide
Read FDA’s announcement (opens in a new tab)Presence of particulate matter and lack of sterility assurance
Read FDA’s announcement (opens in a new tab)Contains garlic essential oil not approved for culinary use
Read FDA’s announcement (opens in a new tab)Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
Read FDA’s announcement (opens in a new tab)Undeclared milk
Read FDA’s announcement (opens in a new tab)Potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) or Salmonella.
Read FDA’s announcement (opens in a new tab)Potential contamination with Salmonella
Read FDA’s announcement (opens in a new tab)Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.
FDA has not published a risk classification for this recall yet.
Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.
FDA has not published a risk classification for this recall yet.
A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
FDA has not published a risk classification for this recall yet.
A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.
FDA has not published a risk classification for this recall yet.
Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
FDA has not published a risk classification for this recall yet.
Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
FDA has not published a risk classification for this recall yet.
Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
FDA has not published a risk classification for this recall yet.
Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
FDA has not published a risk classification for this recall yet.
Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
FDA has not published a risk classification for this recall yet.
Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
FDA has not published a risk classification for this recall yet.
Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
FDA has not published a risk classification for this recall yet.
Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.
FDA has not published a risk classification for this recall yet.
The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the patient if unintended rotational movement occurs during a procedure.
FDA has not published a risk classification for this recall yet.
The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the patient if unintended rotational movement occurs during a procedure.
FDA has not published a risk classification for this recall yet.
There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.
FDA has not published a risk classification for this recall yet.
There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.
FDA has not published a risk classification for this recall yet.
There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical evaluation or therapeutic intervention of an atrial arrhythmia.
FDA has not published a risk classification for this recall yet.
CGMP: Due to not meeting quality requirements (OOS) result for N-Nitroso Mirabegron impurity.
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.
FDA has not published a risk classification for this recall yet.
Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.
FDA has not published a risk classification for this recall yet.
Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.
FDA has not published a risk classification for this recall yet.
Failed Dissolution Specifications
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
CGMP Deviations:Noted during FDA inspection
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
CGMP Deviations:Noted during FDA inspection
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
CGMP Deviations:Noted during FDA inspection
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.